APA (7th ed.) Citation

El-Readi, M. Z., Abdulkarim, M. A., Abdellatif, A. A. H., Elzubeir, M. E., Refaat, B., Althubiti, M., . . . Eid, S. Y. (2025). Doxorubicin-sanguinarine nanoparticles: Formulation and evaluation of breast cancer cell apoptosis and cell cycle. Drug Development & Industrial Pharmacy, 51(9), 987. https://doi.org/10.1080/03639045.2024.2302557

Chicago Style (17th ed.) Citation

El-Readi, Mahmoud Zaki, et al. "Doxorubicin-sanguinarine Nanoparticles: Formulation and Evaluation of Breast Cancer Cell Apoptosis and Cell Cycle." Drug Development & Industrial Pharmacy 51, no. 9 (2025): 987. https://doi.org/10.1080/03639045.2024.2302557.

MLA (9th ed.) Citation

El-Readi, Mahmoud Zaki, et al. "Doxorubicin-sanguinarine Nanoparticles: Formulation and Evaluation of Breast Cancer Cell Apoptosis and Cell Cycle." Drug Development & Industrial Pharmacy, vol. 51, no. 9, 2025, p. 987, https://doi.org/10.1080/03639045.2024.2302557.